Insider transaction details
Olivier Bron, who serves as CEO of Bloomingdale's and is an executive at Macy's Inc., sold 4,712 shares of Macy's common stock (NYSE: M) on March 27, 2026. The proceeds from that sale were approximately $84,406, based on a weighted average sale price of $17.9132 per share. Individual sale prices in the block ranged from $17.8400 to $18.0450.
Concurrent movements in Bron's holdings
On March 26, 2026, Bron recorded an acquisition of 11,035 shares of Macy's common stock with a reported value of $0. In addition, Macy's granted Bron 48,674 restricted stock units, which vest in four equal installments beginning on the first anniversary of the grant date.
Separately, to meet tax obligations associated with the vesting of performance restricted stock units, Bron surrendered 406 shares of common stock. Those surrendered shares were valued at $7,506, reflecting a per-share price of $18.49 for that transaction.
Market context and valuation
At the time of these filings, Macy's stock was trading at $17.58, a level that represents a 19% decline year-to-date while still marking a 44% gain over the prior 12 months. The company is trading at a price-to-earnings ratio of 7.38 and carries a market capitalization of $4.65 billion.
An analysis of the shares indicates they appear slightly overvalued relative to the assessment of Fair Value used by the platform providing that research. That same platform offers additional analytical tips including commentary on the company's dividend record and shareholder yield, plus more detailed research available on request.
Recent operating results and analyst responses
Macy's reported solid fourth-quarter results for fiscal 2025, beating consensus on adjusted diluted earnings per share with $1.67 versus an expected $1.56. Revenue for the quarter reached $7.6 billion, ahead of the $7.46 billion forecast. Management cited positive comparable-store sales across Macy's, Bloomingdale's and Bluemercury as drivers of the upside.
Analysts offered a range of reactions following the results. TD Cowen lowered its price target to $20 while keeping a Hold rating. Telsey similarly set a $20 target and maintained a Market Perform rating. Evercore ISI trimmed its target to $19 and held an In Line rating. By contrast, Jefferies reiterated a Buy rating and a $22 price target, noting the company beat fourth-quarter expectations even though initial fiscal 2026 guidance was below Wall Street estimates.
Takeaway
The insider sale by Bron, combined with newly granted restricted stock units and a tax-related surrender of shares, arrives amid a backdrop of stronger-than-expected quarterly results but divergent analyst views on margins, macro risk and valuation. Investors tracking insider moves and corporate guidance may weigh these filings alongside the mixed analyst reactions when assessing Macy's near-term outlook.